Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988)
- PMID: 1577656
Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988)
Abstract
Long-term follow-up information pertaining to 162 dogs with appendicular osteosarcoma treated by amputation alone was collected from 17 veterinary institutions. The majority (72.5%) of dogs died or were euthanatized because of problems documented to be related to metastases. The first clinically apparent sites of metastasis were the lungs (60.8% of total), the skeleton (5.2%), or both (4.6%). A Kaplan-Meier survivorship distribution was plotted on the basis of available survival time data in all 162 dogs. The mean and median survival times were estimated to be 19.8 and 19.2 weeks, respectively, and the 1- and 2-year survival rates were estimated to be 11.5 and 2.0% respectively. Statistically significant relationships were not found between survival time and reporting institution, gender, site of primary tumor, whether the primary tumor was proximally or distally located, whether the primary tumor was located in the forelimb or hind limb, whether presurgical biopsy was performed, and whether death was tumor related. A significant (P less than 0.01) quadratic relationship was found between age and survival time. Survival time was longest in dogs 7 to 10 years old and was shorter in older and younger dogs.
Similar articles
-
Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990).J Am Vet Med Assoc. 1992 Jun 15;200(12):2005-8. J Am Vet Med Assoc. 1992. PMID: 1639715
-
Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990).J Am Vet Med Assoc. 1992 Feb 15;200(4):531-3. J Am Vet Med Assoc. 1992. PMID: 1559895
-
Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma.J Am Vet Med Assoc. 1995 May 15;206(10):1555-60. J Am Vet Med Assoc. 1995. PMID: 7775232
-
Canine osteosarcoma: amputation and chemoimmunotherapy.Vet Clin North Am Small Anim Pract. 1996 Jan;26(1):123-33. doi: 10.1016/s0195-5616(96)50011-2. Vet Clin North Am Small Anim Pract. 1996. PMID: 8825571 Review.
-
Limb-sparing surgery versus amputation for dogs with bone tumors.Vet Clin North Am Small Anim Pract. 1996 Jan;26(1):135-43. doi: 10.1016/s0195-5616(96)50012-4. Vet Clin North Am Small Anim Pract. 1996. PMID: 8825572 Review.
Cited by
-
Novel acyclic nucleotide analogues GS-343074 and GS-424044 demonstrate antiproliferative and pro-apoptotic activity in canine neoplastic cell lines.Vet Comp Oncol. 2015 Sep;13(3):246-54. doi: 10.1111/vco.12038. Epub 2013 May 15. Vet Comp Oncol. 2015. PMID: 23672437 Free PMC article.
-
Canine osteosarcoma in comparative oncology: Molecular mechanisms through to treatment discovery.Front Vet Sci. 2022 Dec 8;9:965391. doi: 10.3389/fvets.2022.965391. eCollection 2022. Front Vet Sci. 2022. PMID: 36570509 Free PMC article. Review.
-
Case Series: Computed Tomography Features of Extraskeletal Osteosarcoma in Six Dogs.Vet Sci. 2024 Jun 20;11(6):282. doi: 10.3390/vetsci11060282. Vet Sci. 2024. PMID: 38922029 Free PMC article.
-
Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.PLoS One. 2018 Dec 21;13(12):e0209489. doi: 10.1371/journal.pone.0209489. eCollection 2018. PLoS One. 2018. PMID: 30576337 Free PMC article.
-
A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma.Cancer Med. 2019 Jun;8(6):3216-3226. doi: 10.1002/cam4.2177. Epub 2019 Apr 21. Cancer Med. 2019. PMID: 31006987 Free PMC article.
MeSH terms
LinkOut - more resources
Medical